XCUR

XCUR

USD

Exicure Inc. Common Stock

$10.800-0.632 (-5.526%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$11.432

Haut

$11.607

Bas

$10.800

Volume

0.00M

Fondamentaux de l'Entreprise

Capitalisation Boursière

70.3M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.03M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.44Actuel $10.800Haut $36

Actualités Connexes

BusinessWire

Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma

Exicure, Inc. (NASDAQ:XCUR) today announced that GPCR Therapeutics USA, a subsidiary of Exicure Inc., has dosed the 19th patient in its ongoing Phase 2 clinical trial evaluating GPC-100 (burixafor), a small molecule

Voir plus
Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma
BusinessWire

Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)

Exicure, Inc. (NASDAQ:XCUR) today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. ("Exicure") is planning for a clinical trial in Acute Myeloid Leukemia (AML) with

Voir plus
Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.